NeuroPsychoPharmacologie
Tuesday, June 14, 2022
Sessions parallèles
Sessions parallèles
•
S14
•
4:30 PM
>
6:00 PM
•
NeuroPsychoPharmacologie
•
Salle des Thèses
Sessions parallèles
Modérateurs : Luc ZIMMER (Lyon), David DEVOS (Lille)
Conférence invitée
16h30 A new way for drug development in neuropsychopharmacology - Michael SPEDDING, IUPHAR (Paris)
Communications libres
•
CO-019
•
CO-019 - The ERICH3 rs11580409 polymorphism is associated with 6-month antidepressant response in a cohort of depressed patients
>
K.
Kenneth
Chappell
•
CO-020
•
CO-020 - Plasma acetyl-L-carnitine and L-carnitine in major depressive episodes: a case-control study before and after treatment
>
A.
Abd El Kader
AIT TAYEB
•
CO-021
•
CO-021 - Plasma concentration of delta9-tetrahydrocannabinol (THC) and its metabolites and clinical features observed after accidental exposure to cannabis in infants and young children: French addictovigilance data
>
C.
Camille
PONTE
•
CO-022
•
CO-022 - Does concomitant ethanol and diazepam use modulate age-related cognitive decline?
>
L.
Louise
CARTON
•
CO-023
•
CO-023 - Positive perception of a regulation is associated with a change in practice: the example of zolpidem prescription after its new regulation among French general practitioners
>
E-J.
Edouard-Jules
Laforgue
•
CO-024
•
CO-024 - fMRI exploration of a biased agonist of 5-HT1A receptors to treat levodopa-induced dyskinesia in hemiparkinsonian rats
>
S.
Sarah
Chaib
|